A recent study published by university scholars in The Journal of Industrial Economics confirmed how important it is to work with highly qualified professionals to obtain a patent. Indeed, the results of the study confirmed that a higher-quality patent attorney firm can significantly raise the probability of a patent grant.Continue reading
As a strong supporter of the food and beverage industry, Fasken is pleased to invite you to view this episode of the Masterclass Series, presented by BC Food & Beverage (BCFB).
This video series features topics that will be of interest to producers, distributors and retailers in BC’s growing agribusiness, food and beverage industry.
Hear from Roger Kuypers and Janine McNeil, Trademark Agents at Fasken who discuss the importance of trademarks and how an effective trademark strategy is critical to your brand’s future growth and success.
In celebration of this year’s theme for World IP Day, IP and Youth: Innovating for a Better Future, we are exploring the IP implications of emerging technologies that may shape our collective future: (A) artificial intelligence, (B) the metaverse, (C) non-fungible tokens, and (D) clean technologies.Continue reading
Upcoming Changes to Canadian Patent Practice Could Mean Increased Costs. Can you take steps now to mitigate?
As part of the implementation of the patent term adjustment (PTA) obligation in the Canada-United States-Mexico Agreement (“CUSMA”), the Government of Canada proposed a series of amendments to the Canadian Patent Rules to better streamline the patent examination process.
As noted in our earlier blog post, the proposed amendments provided for a request for continued examination requirement and a new notice from the Canadian Intellectual Property Office (“CIPO”) to applicants named a “conditional notice of allowance”, both of which are designed to streamline the patent examination process.Continue reading
UPDATE: On April 14, 2022, the Minister of Health announced that the federal government will not proceed with amendments to the Patented Medicines Regulations introducing new pharmacoeconomic factors and requiring that price and revenue information be reported net of all adjustments. The federal government will proceed with amendments establishing a new basket of comparator countries, with a coming-into-force date of July 1, 2022. For more information, see our Life Sciences Bulletin on the Minister’s announcement.
This article provides an update on each of these cases and highlights the growing body of jurisprudence questioning the PMPRB’s price control reasoning.Continue reading